@misc{indiciaec5ccd22a4a5a,
  title = {The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.},
  author = {Pan, M. and Wright, C. and Chapple, R. and Zubair, A. and Sandhu, M. and Batchelder, J. and Low, J. and Blankenship, K. and Wang, L. and Gordon, B. and Archer, P. and Brady, S. W. and Natarajan, S. and Pozsgai, M. and Schuetz, J. and Miller, D. and Kalathur, R. and chen, s. and Connelly, P. and Babu, M. and Dyer, M. A. and Pruett-Miller, S. M. and Freeman, B. and Chen, T. and Godley, L. and Blanchard, S. and Stewart, E. and Easton, J. and Geeleher, P.},
  year = {2021},
  doi = {10.1101/2021.02.25.432934},
  url = {https://www.biorxiv.org/content/10.1101/2021.02.25.432934v1},
  note = {Source identifier: 10.1101/2021.02.25.432934}
}